Showing results (131-140 of 263) with videos related to
Sort By:
Pageof 27
Annals of Neurology|December 1, 1978
The L-dopa on-off effect in Parkinson disease: treatment by transient drug withdrawal and dopamine receptor resensitizationL Direnfeld, L Spero, J Marotta, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 1, 1982
Striatal binding of 2-amino-6,7-[3H]dihydroxy-1,2,3,4-tetrahydronaphthalene to two dopaminergic sites distinguished by their low and high affinity for neurolepticsS J List, K A Wreggett, P SeemanCanadian Journal of Physiology and Pharmacology|November 1, 1981
Multiple binding sites for [3H]clonidine and [3H]WB-4101 in rat brainP Weinreich, A Chiu, J Warsh, et al.Biochemical and Biophysical Research Communications|April 29, 1988
Dopamine D1 receptors with enhanced agonist affinity and reduced antagonist affinity revealed by chemical modificationN H Bzowej, H B Niznik, P SeemanJournal of Medicinal Chemistry|February 1, 1990
5-HT1 and 5-HT2 binding profiles of the serotonergic agents alpha-methylserotonin and 2-methylserotoninA M Ismaiel, M Titeler, K J Miller, et al.Journal of Medicinal Chemistry|May 1, 1986
Synthesis and evaluation of phenyl- and benzoylpiperazines as potential serotonergic agentsR A Lyon, M Titeler, J D McKenney, et al.Proceedings of the National Academy of Sciences of the United States of America|December 1, 1976
Dopamine receptors in human and calf brains, using [3H]apomorphine and an antipsychotic drugP Seeman, M Chau-Wong, J Tedesco, et al.European Journal of Pharmacology|June 16, 1982
Ascorbate injury and EDTA (or manganese) protection of D2-dopamine receptorsB Chan, P Seeman, A Davis, et al.Journal of Medicinal Chemistry|June 1, 1989
2-Haloaporphines as potent dopamine agonistsS Ramsby, J L Neumeyer, D Grigoriadis, et al.European Journal of Pharmacology|November 14, 1995
Schizophrenia: elevation of dopamine D4-like sites, using [3H]nemonapride and [125I]epideprideP Seeman, H C Guan, H H Van TolPageof 27